Clearance Summary
ACA PLUS FREE THYROXINE(FT4) METHOD received FDA 510(k) clearance under submission number K962602, sponsored by Dade Intl., Inc.. The device was reviewed via the Traditional premarket notification pathway and assigned to the Clinical Chemistry review panel. The statutory decision date of record is 1996-08-15.
- Submission: K962602
- Applicant / Sponsor: Dade Intl., Inc.
- Clearance pathway: Traditional
- Review panel: Clinical Chemistry
- Device class: Class II
- Regulation citation: 21 CFR 862.1695
- Decision date: 1996-08-15
Classification & Regulation
This clearance is catalogued under FDA product code CEC and 21 CFR 862.1695, within the Clinical Chemistry review panel as a Class II device.